Many investigators pivoted to SARS-CoV-2 and COVID-19 science and medicine in 2020. We did too at BHC because we understood the opportunity the pandemic provided for "real-time" clinical research of post-COVID-19 sequelae and to share all we know about ME/CFS -...
Share Your Message of Hope It’s time to start preparing for ME/CFS and FM Awareness Day! We are holding the 3rd annual Messages of Hope virtual event on May 11th, one day early this year because Dr. Bateman is speaking about ME/CFS at the Long COVID and Fatiguing...
At a time when the world is reeling from conflict, anger and disillusion, we may be hesitant to trust the light on our COVID-19 horizon, but I’d like to share hopeful news. For COVID long haulers: there is an ever-growing scientific and medical response to your...
Despite having worked in the medical field for 15 years, I first learned about ME/CFS during an education lecture Dr. Bateman gave at the University of Utah Health where I was a health educator. During this presentation, I started to see the puzzle pieces of my...
In the coming weeks, BHC will start a new research study that you may be eligible to participate in! This research will assess endothelial function and upright activity in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID, which is...
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a waypoint in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
When Cortene contacted BHC with an idea, and an early draft protocol designed to test CT38 as a treatment for ME/CFS, Dr. Suzanne Vernon and I agreed to help them refine the protocol and conduct the trial. The Cortene-funded trial was an FDA and IRB-approved...
Frontiers in Systems Neuroscience published the study results of Cortene Inc's investigational drug CT38 in people with ME/CFS. The trial was conducted at Bateman Horne Center and Suzanne Vernon, PhD, wrote a blog post providing context about the study. Cortene Inc....
In 2018 the Food and Drug Administration approved a physician-sponsored Investigational New Drug (IND) Application, to investigate the safety, tolerability and efficacy of CT38 in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Dr....
My family and I recently returned to Salt Lake City after a 22-year absence. We had missed Utah’s western landscape and snowcapped mountains and the youthful feeling of the city. Additionally, I knew there would be unique professional opportunities available to me in...
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a way point in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a way point in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.